Table 4.
Total (n=878) |
< 18.5 (Q1, n=30) |
18.5-23.9 (Q2, n=360) | 24.0-28.9 (Q3, n=384) | ≥ 29 (Q4, n=104) |
a P | b P | c P | |
---|---|---|---|---|---|---|---|---|
IIEF−5 score, n (%) | 0.57 | 0.94 | 0.001 | |||||
5-11 | 20 (2.3) | 1 (3.4) | 7 (1.9) | 8 (2.1) | 4 (3.8) | |||
12-16 | 97 (11.1) | 3 (10.0) | 37 (10.3) | 38 (9.9) | 19 (18.3) | |||
17-21 | 349 (39.7) | 13 (43.3) | 140 (38.9) | 149 (38.8) | 47 (45.2) | |||
22-25 | 412 (46.9) | 13 (43.3) | 176 (48.9) | 189 (49.2) | 34 (32.7) |
BMI, body mass index; IIEF-5, International Index of Erectile Function questionnaire. Chi-square test for trend.
P, Q2 vs Q1;
P, Q2 vs Q3;
P, Q2 vs Q4.